Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Biochemistry

• Publication date

  1994-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/BI00172A037PMID 8312277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thermodynamic analysis of an antibody functional epitope.

  1993cited by this paper
• Isolation and characterization of proteolytic fragments of human factor VIIa which inhibit the tissue factor-enhanced amidolytic activity of factor VIIa.

  1993cited by this paper
• Structure‐function analysis of human IL‐6 receptor: dissociation of amino acid residues required for IL‐6‐binding and for IL‐6 signal transduction through gp130.

  1993cited by this paper
• Structural requirements for the interaction between tissue factor and factor VII: characterization of chymotrypsin-derived tissue factor polypeptides.

  1993cited by this paper
• Effects of substitutions of closely related amino acids at the contact surface in an antigen-antibody complex on thermodynamic parameters.

  1993cited by this paper
• Mutational analysis of receptor and cofactor function of tissue factor.

  1993cited by this paper
• Identification of three adjacent amino acids of interleukin‐2 receptor beta chain which control the affinity and the specificity of the interaction with interleukin‐2.

  1992cited by this paper
• The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions.

  1992cited by this paper
• Identification of ligand binding determinants of the prolactin receptor.

  1992cited by this paper
• Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex.

  1992cited by this paper
• Tissue factor residues 157-167 are required for efficient proteolytic activation of factor X and factor VII.

  1992cited by this paper
• Human epidermal growth factor

  1992cited by this paper
• The evaluation of complex-dependent alterations in human factor VIIa.

  1992cited by this paper
• Purification, sequence and crystallization of an anti-tissue factor Fab and its use for the crystallization of tissue factor

  1992cited by this paper
• Structure of mouse interleukin 3 (IL-3) binding protein (AIC2A). Amino acid residues critical for IL-3 binding.

  1992cited by this paper
• Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex.

  1992cited by this paper
• The interaction of human factor VIIa with tissue factor.

  1992cited by this paper
• Human epidermal growth factor. High resolution solution structure and comparison with human transforming growth factor alpha.

  1992cited by this paper
• Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

  1992cited by this paper
• Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male.

  1991cited by this paper
• Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.

  1991cited by this paper
• Antibody mapping of tissue factor implicates two different exon-encoded regions in function.

  1991cited by this paper
• A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor.

  1991cited by this paper
• Localization of the human tissue factor recognition determinant of human factor VIIa.

  1991cited by this paper
• The Structural Biology of Expression and Function of Tissue Factor

  1991cited by this paper
• The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII.

  1991cited by this paper
• The coagulation cascade: initiation, maintenance, and regulation.

  1991cited by this paper
• Integrin alpha IIb beta 3 (platelet GPIIb-IIIa) recognizes multiple sites in fibronectin.

  1991cited by this paper
• Role of type III homology repeats in cell adhesive function within the cell-binding domain of fibronectin.

  1991cited by this paper
• Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions.

  1991cited by this paper
• An Anti-Tissue Factor Monoclonal Antibody which Inhibits TF Vlla Complex Is a Potent Anticoagulant in Plasma

  1991cited by this paper
• Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function.

  1991cited by this paper
• Two sites in the tissue factor extracellular domain mediate the recognition of the ligand factor VIIa.

  1991cited by this paper
• A rapid method for recombination and site-specific mutagenesis by placing homologous ends on DNA using polymerase chain reaction.

  1991cited by this paper
• Lysine residues 165 and 166 are essential for the cofactor function of tissue factor.

  1991cited by this paper
• A new analysis of proton chemical shifts in proteins

  1991cited by this paper
• Additivity of mutational effects in proteins.

  1990cited by this paper
• Structural design and molecular evolution of a cytokine receptor superfamily.

  1990cited by this paper
• The gamma-carboxyglutamic acid domain of human factor VIIa is essential for its interaction with cell surface tissue factor.

  1990cited by this paper
• Diversity of the immunoglobulin gene superfamily.

  1989cited by this paper
• Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.

  1988cited by this paper
• Secretion of mature mouse interleukin-2 by Saccharomyces cerevisiae: use of a general secretion vector containing promoter and leader sequences of the mating pheromone alpha-factor.

  1985cited by this paper

• Human missense variants in F3 impair the initiation of blood coagulation.

  2025cites this paper
• Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies.

  2018cites this paper
• The Role of Coagulation Factor Signaling in Angiogenesis and Vascular Remodeling

  2015cites this paper
• Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation

  2014influential citation
• Comparison of natural and recombinant tissue factor proteins: new insights

  2013cites this paper
• Structural biology of factor VIIa/tissue factor initiated coagulation.

  2012cites this paper
• NMR investigations of blood coagulation: Conformational changes of membrane bilayers and proteins in blood coagulation

  2010cites this paper
• Die Bedeutung der Tissue Factor - abhängigen Signaltransduktion für die zelluläre Funktion der Kardiomyozyten

  2010cites this paper
• Loop dynamics of the extracellular domain of human tissue factor and activation of factor VIIa.

  2009influential citation
• Role of Alternatively Spliced Tissue Factor in Pancreatic Cancer Growth and Angiogenesis

  2008cites this paper
• Full-length cDNA cloning and protein three-dimensional structure modeling of factor VII of rhesus monkey, Macaca mulatta.

  2008cites this paper
• Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis.

  2008cites this paper
• The changing faces of tissue factor biology

  2007cites this paper
• Identification of a basic region on tissue factor that interacts with the first epidermal growth factor-like domain of factor X.

  2007cites this paper
• Alternatively spliced tissue factor – One cut too many?

  2007influential citation
• The Cofactor Function of the N-terminal Domain of Tissue Factor*

  2004cites this paper
• Tissue factor: (patho)physiology and cellular biology

  2004cites this paper
• Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy.

  2004cites this paper
• Tissue factor alters the pK(a) values of catalytically important factor VIIa residues.

  2002cites this paper
• Structure, function, and activation of coagulation factor VII.

  2002cites this paper
• The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening.

  2002cites this paper
• Cellular signalling by tissue factor and lipoproteins in the pathogenesis of atherosclerosis.

  2002cites this paper
• The tissue factor region that interacts with factor Xa in the activation of factor VII.

  2001cites this paper
• Factor VII deficiency and the FVII mutation database

  2001cites this paper
• Contribution of tryptophan residues to the CD spectrum of the extracellular domain of human tissue factor: application in folding studies and prediction of secondary structure.

  2001cites this paper
• Spin and fluorescent probing of the binding interface between tissue factor and factor VIIa at multiple sites.

  2001cites this paper
• Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor.

  2001cites this paper
• The TF:VIIa Complex: Clinical Significance, Structure-function Relationships and Its Role in Signaling and Metastasis

  2001cites this paper
• Molecular analysis of the genotype-phenotype relationship in factor VII deficiency

  2000cites this paper
• Cloning of Guinea Pig Tissue Factor cDNA: Comparison of Primary Structure among Six Mammalian Species

  2000cites this paper
• Spectroscopic probing of the influence of calcium and the gla domain on the interaction between the first EGF domain in factor VIIa and tissue factor.

  2000cites this paper
• Anomalies de la voie du facteur tissulaire en pathologie thrombotique veineuse

  2000cites this paper
• Properties of spin and fluorescent labels at a receptor-ligand interface.

  1999cites this paper
• Crystal Structures of Soluble Tissue Factor and Factor VIIa-Tissue Factor Complex

  1999cites this paper
• Faktor VII und Gewebethromboplastin: Der extrinsische Aktivierungskomplex

  1999cites this paper
• The role of the C‐terminal domain in the inhibitory functions of tissue factor pathway inhibitor

  1999cites this paper
• Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis.

  1998cites this paper
• Anatomy of hot spots in protein interfaces.

  1998cites this paper
• Structural basis for cytokine hormone-receptor recognition and receptor activation.

  1998cites this paper
• A Novel Soluble Tissue Factor Variant with an Altered Factor VIIa Binding Interface*

  1998cites this paper
• Mechanism of tissue factor activation on cells.

  1998cites this paper
• Immunological and Functional Analyses of the Extracellular Domain of Human Tissue Factor

  1998cites this paper
• Changes of tissue factor activity on inflammatory stimulus and aging in rat

  1998cites this paper
• Tissue factor and biotechnology.

  1998cites this paper
• The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex.

  1998cites this paper
• Molecular interaction between factor VII and tissue factor.

  1998cites this paper
• Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.

  1998cites this paper
• Modification of tissue factor by peroxynitrite influences its procoagulant activity

  1998cites this paper
• Coagulation Factor VII Gln100 → Arg

  1998cites this paper
• Identification of a domain in apolipoprotein B-100 that inhibits the procoagulant activity of tissue factor.

  1998cites this paper
• The interaction of activated factor VII with tissue factor: insight into the mechanism of cofactor-mediated activation of activated factor VII.

  1998cites this paper
• Analysis of the Human Factor VIII A2 Inhibitor Epitope by Alanine Scanning Mutagenesis*

  1997cites this paper
• The Structural Basis of Function of the TF●VIIa Complex in the Cellular Initiation of Coagulation

  1997cites this paper
• Molecular and structural advances in tissue factor-dependent coagulation.

  1997cites this paper
• A peptide sequence from the EGF-2 like domain of FVII inhibits TF-dependent FX activation.

  1997cites this paper
• Inherited Factor X Deficiency: Molecular Genetics and Pathophysiology

  1997cites this paper
• Inherited Factor VII Deficiency: Molecular Genetics and Pathophysiology

  1997cites this paper
• The Factor Vlla / Tissue Factor Complex

  1997cites this paper
• A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent.

  1997cites this paper
• Molecular and Structural Tissue Factor-Dependent

  1997cites this paper
• Display of fixed residues on variable cyclic scaffolds: A novel approach to peptide combinatorial library synthesis

  1997cites this paper
• Tissue Factor residue Asp44 regulates catalytic function of the bound proteinase Factor VIIa.

  1996cites this paper
• Identification of a Critical Ligand Binding Determinant of the Human Erythropoietin Receptor

  1996cites this paper
• Cell biology of tissue factor, the principal initiator of blood coagulation.

  1996cites this paper
• Domain Interplay in the Urokinase Receptor

  1996cites this paper
• Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa.

  1996cites this paper
• The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor

  1996cites this paper
• Activation of Factor X by Factor VIIa Complexed with Human-mouse Tissue Factor Chimeras Requires Human Exon 3

  1996cites this paper
• The crystal structure of the extracellular domain of human tissue factor refined to 1.7 A resolution.

  1996cites this paper
• The tissue factor-factor VII complex: recent advances towards elucidating the structure and function of the initiator of haemostasis.

  1996cites this paper
• Synthetic peptide analogs of tissue factor and factor VII which inhibit factor Xa formation by the tissue factor/factor VIIa complex.

  1996cites this paper
• Initiation of blood coagulation: the tissue factor/factor VIIa complex.

  1996cites this paper
• Alpha and beta interferons and their receptor and their friends and relations.

  1995cites this paper
• Tissue Factor Modulation of Factor Vlla Activity:Use in Measuring Trace Levels of Factor Vlla in Plasma

  1995cites this paper
• Activation of blood coagulation factor VIIa with cleaved tissue factor extracellular domain and crystallization of the active complex

  1995cites this paper
• Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor.

  1995cites this paper
• Inherited Factor VII Deficiency: Genetics and Molecular Pathology

  1995cites this paper
• Environments of the four tryptophans in the extracellular domain of human tissue factor: comparison of results from absorption and fluorescence difference spectra of tryptophan replacement mutants with the crystal structure of the wild-type protein.

  1995cites this paper
• Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization.

  1995cites this paper
• Saturation Mutagenesis of Human Interleukin-3 (*)

  1995cites this paper
• Spectral enhancement of recombinant proteins with tryptophan analogs: The soluble domain of human tissue factor

  1995cites this paper
• Molecular Biology of Tf

  1995cites this paper
• α and α Interferons and Their Receptor and Their Friends and Relations

  1995influential citation
• Tissue Factor: molecular recognition and cofactor function

  1995influential citation
• The Tissue Factor Pathway: How It Has Become a “Prima Ballerina”

  1995cites this paper
• Four-helix bundle growth factors and their receptors: protein-protein interactions.

  1995cites this paper
• Energetic contributions and topographical organization of ligand binding residues of tissue factor.

  1995cites this paper
• Analysis of the factor VIIa binding site on human tissue factor: effects of tissue factor mutations on the kinetics and thermodynamics of binding.

  1995cites this paper
• Tissue Factor

  1995cites this paper
• Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.

  1995cites this paper
• A peptide derived from a tissue factor loop region functions as a tissue factor--factor VIIa antagonist.

  1995cites this paper
• Chemical cross-linking of activated coagulation factor VII with soluble tissue factor: calcium ions are not essential for full amidolytic activity of the factor VIIa-tissue factor complex after complex formation.

  1995cites this paper
• Coagulation factors and their inhibitors.

  1994cites this paper
• Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site.

  1994cites this paper
• Crystal structure of the extracellular region of human tissue factor

  1994cites this paper
• Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304-->Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor.

  1994cites this paper
• Factor VIIa residue Arg290 is required for efficient activation of the macromolecular substrate factor X.

  1994cites this paper
• Identification of the factor VIIa binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis.

  1994cites this paper
• Crystal structure of the extracellular region of human tissue factor

  1994cites this paper
• Key ligand interface residues in tissue factor contribute independently to factor VIIa binding.

  1994cites this paper